Response to Comment on: “First-line tagraxofusp leads to durable responses and prolonged survival in adults with blastic plasmacytoid dendritic cell neoplasm regardless of fitness level”

Comments

The University of Texas MD Anderson Cancer Center, Houston, TX

Dana-Farber Cancer Institute, Boston, MA

Haematologica Early view Oct 22, 2026 https://doi.org/10.3324/haematol.2026.302103

Abstract

Not available.

Early view : Comments

DOI

Pubmed

Published

2026-10-22

Published By

Ferrata Storti Foundation, Pavia, Italy

Print ISSN

0390-6078

Online ISSN

1592-8721

Copyright & Usage

Online Views

65

PDF Downloads

56

No Data

PlumX